MedTrace Logo

The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients

NCT07442370 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-03-03

No results posted yet for this study

Summary

This study aims to contribute to clinical applications by investigating the effectiveness of functional rotation exercises on fall risk, mobility, and balance in patients diagnosed with idiopathic Parkinson's disease.

Conditions

  • Parkinson Disease
  • Parkinsonism

Interventions

OTHER

conventional physiotherapy

Conventional physiotherapy will be applied for 6 weeks, with 3 sessions per week, each session lasting approximately 40-50 minutes. Participants will be given stretching and flexibility exercises (trunk, shoulder and lower extremity muscle groups) in each session, with 10 repetitions x 15 seconds. Balance exercises (3 repetitions for 30-45 seconds in static and dynamic balance positions), walking exercises on a flat surface, and strengthening exercises (2-3 sets, 10-12 repetitions with resistance band or dumbbells) will be performed.

OTHER

conventional physiotherapy + exercise

This group will receive conventional physical therapy and functional rotation exercises for 6 weeks, with 3 sessions per week, each session lasting approximately 40-50 minutes.

Sponsors & Collaborators

  • Uskudar University

    lead OTHER

Principal Investigators

  • Kübra UZUN · Uskudar University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2026-07-15
Completion
2026-09-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07442370 on ClinicalTrials.gov